EFDID: 253236EFD: View Filing

Issuer: Verrica Pharmaceuticals Inc. (0001660334) - D

Accession: 0001660334-17-000003 (XMLRaw Data) (EDGAREDGAR Files) (Form DForm D)

EDGAR: Issuer Information
  • CIK:
    0001660334
  • Entity Name:
    Verrica Pharmaceuticals Inc.
  • Entity Type:
    Corporation
  • Jurisdiction:
    DELAWARE
  • Year of Inc:
    Within 5 years (2013)
  • Address:
    200 Garrett Street
    Suite S
    Charlottesville, VA 22902
  • Persons:
    Related Persons 6
    Matthew Davidson
    Executive Officer, Director, Promoter
    Sean Stalfort
    Director, Promoter
    Jayson Rieger
    Executive Officer, Director, Promoter
    Paul Manning
    Executive Officer, Director, Promoter
    Glenn Oclassen
    Director, Promoter
    James C. Reebals
    Executive Officer, Promoter
EDGAR: Offering Information
  • Accession Date:
    12/22/2017
  • First Sale Date:
    12/15/2017
  • Offering Amount:
    $5,000,000
  • Amount Sold:
    $5,000,000
  • Exemptions:
    Rule 506
  • Security Type(s):
    Equity
EFD: Current State Notices

No State Notices found in EFD

EDGAR: Sales Compensation Recipient Information

There were no Sales Compensation Recipient Information associated with this Accession Number.

EDGAR: Signatures
IssuerSignatureSigner NameTitleSignatureDate
Verrica Pharmaceuticals Inc./James C. Reebals/James C. ReebalsCFO2017-12-22